BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Aurinia Reports Fourth Quarter and Full Year 2019 Financial Results and Operational Highlights

  Cash and cash equivalents totaled approximately $306 million at December 31, 2019

  March 5, 2020

   · 

  19 min read
• NuCana Receives Positive Opinion for Orphan Drug Designation in the European Union for Acelarin (NUC-1031) for the Treatment of Patients with Biliary Tract Cancer

  NuCana plc (NASDAQ: NCNA) announced that the European Medicines Agency’s (EMA) Committee for Orphan Medicinal Products (COMP) has issued a positive opinion for orphan drug designation of Acelarin for the treatment of patients with biliary tract cancer

  March 5, 2020

   · 

  6 min read
• Genetown

  Alexion Announces Upcoming Data Presentations at 72nd Annual Meeting of the American Academy of Neurology

  Nine abstracts accepted, including long-term data and subgroup analyses from the Phase 3 PREVENT clinical trial evaluating SOLIRIS® (eculizumab) for the treatment of neuromyelitis optica spectrum disorder (NMOSD)

  March 5, 2020

   · 

  13 min read